80 related articles for article (PubMed ID: 29775811)
21. Smart sampling as the "Spot-on" Method for LC-MS protein analysis from dried blood spots.
Johannsen C; Mrsa A; Halvorsen TG; Reubsaet L
J Sep Sci; 2023 Sep; 46(18):e2300394. PubMed ID: 37582644
[TBL] [Abstract][Full Text] [Related]
22. A LC-MS/MS Method for Quantifying Adenosine, Guanosine and Inosine Nucleotides in Human Cells.
Jimmerson LC; Bushman LR; Ray ML; Anderson PL; Kiser JJ
Pharm Res; 2017 Jan; 34(1):73-83. PubMed ID: 27633886
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a UPLC-PDA method for quantifying ceftazidime in dried blood spots.
Lv J; Wu Q; Li S; Yi H; Xie F
J Pharm Biomed Anal; 2024 Feb; 239():115928. PubMed ID: 38134705
[TBL] [Abstract][Full Text] [Related]
24. A feasible protocol to profile bile acids in dried blood spots from rats using a UHPLC-MS/MS method combining a surrogate matrix.
Ma Z; Sheng N; Zhang J
Analyst; 2023 Oct; 148(20):5190-5202. PubMed ID: 37721130
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of plasma and dried blood spot metabolomics and its application to diabetes mellitus.
Chiu HH; Lin SY; Zhang CG; Tsai CC; Tang SC; Kuo CH
Clin Chim Acta; 2024 Jan; 552():117655. PubMed ID: 37977234
[TBL] [Abstract][Full Text] [Related]
26. Measurement of intracellular ribavirin mono-, di- and triphosphate using solid phase extraction and LC-MS/MS quantification.
Jimmerson LC; Ray ML; Bushman LR; Anderson PL; Klein B; Rower JE; Zheng JH; Kiser JJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():163-72. PubMed ID: 25555148
[TBL] [Abstract][Full Text] [Related]
27. Quantification of ceftazidime/avibactam in human plasma and dried blood spots: Implications on stability and sample transport.
Martens-Lobenhoffer J; Angermair S; Bode-Böger SM
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Mar; 1193():123164. PubMed ID: 35196625
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive lipidomic profiling by plasma separation cards.
Bishop LM; Fiehn O
Anal Bioanal Chem; 2023 Jan; 415(1):193-201. PubMed ID: 36316462
[TBL] [Abstract][Full Text] [Related]
29. Dried urine spot (DUS) applied for sampling prior to the accurate HILIC-MS/MS determination of 14 amino acids.
Meikopoulos T; Begou O; Gika H; Theodoridis G
Talanta; 2024 Mar; 269():125489. PubMed ID: 38096631
[TBL] [Abstract][Full Text] [Related]
30. LC-MS/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots.
Prathipati PK; Mandal S; Destache CJ
Biomed Chromatogr; 2018 Apr; ():e4270. PubMed ID: 29700852
[TBL] [Abstract][Full Text] [Related]
31. Dried Blood Spots-A Platform for Therapeutic Drug Monitoring (TDM) and Drug/Disease Response Monitoring (DRM).
Zailani NNB; Ho PC
Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):467-494. PubMed ID: 37495930
[TBL] [Abstract][Full Text] [Related]
32. Determination of remifentanil in neonatal dried blood spots by liquid chromatography-tandem mass spectrometry.
Trontelj J; Rozman A; Mrhar A
Acta Pharm; 2024 Jun; 74(2):343-354. PubMed ID: 38815198
[TBL] [Abstract][Full Text] [Related]
33. Performance of laboratory tests used to measure blood phenylalanine for the monitoring of patients with phenylketonuria.
Moat SJ; Schulenburg-Brand D; Lemonde H; Bonham JR; Weykamp CW; Mei JV; Shortland GS; Carling RS
J Inherit Metab Dis; 2020 Mar; 43(2):179-188. PubMed ID: 31433494
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic drug monitoring for lisinopril in rats using dried blood spots.
T AlQuadeib B; M Alfagih I; Aldosari B; Almurshedi A
Pak J Pharm Sci; 2023 May; 36(3(Special)):1017-1024. PubMed ID: 37587712
[TBL] [Abstract][Full Text] [Related]
35. Repurposing dried blood spot device technology to examine bile acid profiles in human dried fecal spot samples.
Engevik MA; Thapa S; Lillie IM; Yacyshyn MB; Yacyshyn B; Percy AJ; Chace D; Horvath TD
Am J Physiol Gastrointest Liver Physiol; 2024 Feb; 326(2):G95-G106. PubMed ID: 38014449
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the relationship between phenylalanine in venous plasma and capillary blood using volumetric blood collection devices.
Carling RS; Barclay Z; Cantley N; Emmett EC; Hogg SL; Finezilber Y; Schulenburg-Brand D; Murphy E; Moat SJ
JIMD Rep; 2023 Nov; 64(6):468-476. PubMed ID: 37927487
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of an LC-MSMS method to quantify creatinine from dried blood spots.
Torres C; Muldrow RA; Naranjo AR; Cotten SW; Pierre CC; Greene DN
J Mass Spectrom Adv Clin Lab; 2024 Apr; 32():50-59. PubMed ID: 38511102
[TBL] [Abstract][Full Text] [Related]
38. Trace analysis of per- and polyfluorinated alkyl substances (PFAS) in dried blood spots - Demonstration of reproducibility and comparability to venous blood samples.
Lin EZ; Nason SL; Zhong A; Fortner J; Godri Pollitt KJ
Sci Total Environ; 2023 Jul; 883():163530. PubMed ID: 37094673
[TBL] [Abstract][Full Text] [Related]
39. Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.
Le J; Poindexter B; Sullivan JE; Laughon M; Delmore P; Blackford M; Yogev R; James LP; Melloni C; Harper B; Mitchell J; Benjamin DK; Boakye-Agyeman F; Cohen-Wolkowiez M
Ther Drug Monit; 2018 Feb; 40(1):103-108. PubMed ID: 29271816
[TBL] [Abstract][Full Text] [Related]
40. Do dried blood spots have the potential to support result management processes in routine sports drug testing?-Part 3: LC-MS/MS-based peptide analysis for dried blood spot sampling time point estimation.
Brockbals L; Thomas A; Schneider TD; Kraemer T; Steuer AE; Thevis M
Drug Test Anal; 2023 Feb; ():. PubMed ID: 36829300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
